Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

98 results about "Contagious disease" patented technology

A disease that can spread from one person to another through direct or indirect contact.

Self-contained device integrating nucleic acid extraction, amplification and detection

A self-contained device is described that integrates nucleic acid extraction, specific target amplification and detection into a single device. This integration permits rapid and accurate nucleic acid sequence detection. The invention may be used, for example, in the screening for nucleic acid sequences which may be indicative of genetic defects or contagious diseases, as well as for monitoring efficacy in the treatment of contagious diseases.
Owner:APPL BIOSYSTEMS INC

Method and system for taking public elevator without contact, control device and storage medium

The invention provides a method and system for taking a public elevator without contact, a control device and a storage medium. The method applied to a cloud comprises the following steps of receivingan elevator taking instruction sent by terminal equipment and through the Internet by a first application set thereon; determining a corresponding target elevator object according to the elevator taking instruction; and controlling the target elevator object through the Internet to execute the elevator taking instruction, wherein the execution of the elevator taking instruction by the target elevator object comprises at least starting up a specified key corresponding to the target elevator object to make the car corresponding to the target elevator object move to a specified floor. The invention is conducive to the safe and healthy elevator use of elevator users, so as to solve the problem that contagious viruses spread by pressing the elevator buttons.
Owner:SHENZHEN WONGLONG INTELLIGENT TECH

Live attenuated antigenically marked classical swine fever virus

Classical swine fever virus is a world-wide distributed highly-contagious disease affecting swine. The two main strategies for diseases control are prophylactic vaccination and non-vaccination stamping out policies. Marker vaccines are a promising strategy. Here we report the rational development of a doubly antigenic marker CSFV experimental live attenuated candidate strain vaccine (Flag/T4 virus). Flag/T virus (Flag/T4v) is based in the combination of two Brescia derived recombinant attenuated viruses: RB-C22 and T4. RB-C22v contains a 19mer insertion in the structural glycoprotein E1, while T4v posses mutated CSFV amino acid residues 830 to 834 in the structural glycoprotein E2, deleting the highly conserved epitope recognized by monoclonal antibody (mAb) WH303. Flag/T4 virus contains a positive foreign antigenic marker, due to the insertion of the highly antigenic epitope Flag in the 19mer insertion of E1, as well as a negative antigenic marker, the lack of reactivity with mAb WH303. Immunized with Flag/T4v induced a complete protection against the challenge with virulent strain Brescia both at 3 and 28 days post infection when nasally administered and since the second day post infection when intramuscularly administered. These results constitute an example of rational design of a CSFV antigenically marked LAV.
Owner:AGRI UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC OF THE +1

Medication dispenser

This invention relates to a tamper resistant medication dispenser. The medication dispenser is programmed to dispense a specified dose of medication at a specified interval. The medication dispenser prevents direct access to the medication by the patient. The medication is dispensed to the patient dissolved in a large volume of liquid to prevent intravenous and intranasal abuse. The medication dispenser can be equipped with a self destruct mechanism when tampered with and have the ability to record video for subsequent monitoring, the actual medication ingestion of the medication infused liquid by the patient. It is especially useful for controlled substances which have high potential for abuse such as opioids, benzodiazepines and barbiturates and anesthetic agents and when patient compliance with medications is necessary such as medications for the treatment of contagious diseases.
Owner:SANDHU AMANPREET

Indazolinone compositions useful as kinase inhibitors

The present invention provides compounds of formula I:These compounds, and pharmaceutically acceptable compositions thereof, are useful generally as kinase inhibitors, particularly as inhibitors of PRAK, GSK3, ERK2, CDK2, MK2, SRC, SYK, and Aurora-2. Accordingly, compounds and compositions of the invention are useful for treating or lessening the severity of a variety of disorders, including, but not limited to, heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases and viral diseases.
Owner:VERTEX PHARMA INC

Portable specific vomit device for infectious disease

The invention relates to a portable specific vomit device for an infectious disease and belongs to the technical field of medical utensils. The portable specific vomit device for the infectious disease comprises a box body. An operation panel is arranged on the front side of the box body; a flushing water box is arranged on the left side of the box body; the lower side of the flush water box is provided with a power supply box; an auxiliary back belt is mounted on the rear side of the box body; a foldable combination hose is mounted on the upper side of the box body; a moth mask accommodatingbox is formed in the right side of the foldable combination hose; a hose fixing clip is cooperated to the upper surface of the foldable combination hose; a sealing mouth mask is mounted on the upper side of the foldable combination hose; a disinfection and sterilizing box is disposed in the box body; a flushing protection plate is placed in the sealing mouth mask; a diversion flushing groove is formed in the right side of the flushing protection plate; and a flushing nozzle is formed in the upper side of the diversion flushing groove. The portable specific vomit device for the infectious disease is simply structured and convenient to use; an infectious disease patient can carry the device, so vomit can be flushed and sealed, and odor of the vomit and saliva splash can be prevented; and patient vomit can be sterilized and disinfected, so bacteria can be fully killed and cross infection can be avoided.
Owner:孙燕妮

Infectious disease isolating and sterilizing equipment

The invention relates to medical-care equipment for isolating and sterilizing a patient and protecting other people from being infected. The equipment consists of a mask, a sterilizing device, an electronic control device and constant power supply facilities, wherein the sterilizing device, the electronic control device and the constant power supply facilities are arranged in a sterilizing tank; the sterilizing device consists of a high-voltage electrostatic field, an ultraviolet sterilizing lamp and an electric fan; and expired gas goes first through absorption by the electrostatic field in the sterilizing device, then through radiation by an ultraviolet sterilizing lamp for sterilization, disinfection and purification and finally through the electrical fan before being discharged into the atmosphere. The results of clinic nursing trials in hospitals indicate that the isolating and sterilizing equipment is capable of disinfecting and sterilizing and has good isolating effect and high working efficiency. The equipment is applicable to treatment in hospital and nursing at home, particularly emergent rescue, patient transfer and rescue of patients in danger.
Owner:赵洪涛

Live attenuated antigenically marked classical swine fever virus

Classical swine fever virus is a world-wide distributed highly-contagious disease affecting swine. The two main strategies for diseases control are prophylactic vaccination and non-vaccination stamping out policies. Marker vaccines are a promising strategy. Here we report the rational development of a doubly antigenic marker CSFV experimental live attenuated candidate strain vaccine (Flag / T4 virus). Flag / T virus (Flag / T4v) is based in the combination of two Brescia derived recombinant attenuated viruses: RB-C22 and T4. RB-C22v contains a 19mer insertion in the structural glycoprotein E1, while T4v posses mutated CSFV amino acid residues 830 to 834 in the structural glycoprotein E2, deleting the highly conserved epitope recognized by monoclonal antibody (mAb) WH303. Flag / T4 virus contains a positive foreign antigenic marker, due to the insertion of the highly antigenic epitope Flag in the 19mer insertion of E1, as well as a negative antigenic marker, the lack of reactivity with mAb WH303. Immunized with Flag / T4v induced a complete protection against the challenge with virulent strain Brescia both at 3 and 28 days post infection when nasally administered and since the second day post infection when intramuscularly administered. These results constitute an example of rational design of a CSFV antigenically marked LAV.
Owner:AGRI UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC OF THE +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products